Mild Neurocognitive Impairment in HIV Infection Is Associated with Neuroinflammation on Positron Emission Tomography (S37.003)

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. S37.003-S37.003
Author(s):  
W. Kreisl ◽  
A. Brown ◽  
C. H. Lyoo ◽  
Y. Zhang ◽  
C. Morse ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Hiv Infection ◽  
Neurocognitive Impairment ◽  
Emission Tomography ◽  
Positron Emission

Mild Neurocognitive Impairment in HIV Infection Is Associated with Neuroinflammation on Positron Emission Tomography (IN3-1.008)

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. IN3-1.008-IN3-1.008
Author(s):  
W. Kreisl ◽  
A. Brown ◽  
C. H. Lyoo ◽  
Y. Zhang ◽  
C. Morse ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Hiv Infection ◽  
Neurocognitive Impairment ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People With Treated HIV Infection

2020 ◽  
Vol 83 (3) ◽  
pp. e23-e25
Author(s):  
Scott E. Janus ◽  
Claire Sullivan ◽  
Justin Morrison ◽  
Grace A. McComsey ◽  
Chris T. Longenecker
Keyword(s):  
Positron Emission Tomography ◽  
Hiv Infection ◽  
Emission Tomography ◽  
Fat Pad ◽  
Positron Emission

Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)

1996 ◽  
Vol 7 (5) ◽  
pp. 337-346 ◽  
Author(s):  
Alison E. Heald ◽  
John M. Hoffman ◽  
John A. Bartlett ◽  
Hetty A. Waskin
Keyword(s):  
Positron Emission Tomography ◽  
Central Nervous System ◽  
Nervous System ◽  
Hiv Infection ◽  
Metabolic Activity ◽  
Fdg Pet ◽  
Emission Tomography ◽  
Cns Lymphoma ◽  
Positron Emission ◽  
Cns Lesions

To determine if positron emission tomography (PET) imaging using F-18 fluorodeoxyglucose (FDG) can accurately distinguish between malignant and infectious central nervous system (CNS) mass lesions in patients with human immunodeficiency virus (HIV) infection, a prospective case series of 18 patients with HIV infection and focal CNS lesions on computed tomography (CT) or magnetic resonance (MR) scans was analysed. The patients were divided into 3 groups based on biopsy results, serology and response to therapy. Group 1 consisted of 8 patients with infectious lesions (4 with toxoplasmosis, 2 with neurosyphilis, 2 with progressive multifocal leukoencephalopathy (PML) ). Group 2 consisted of 5 patients with biopsy proven CNS lymphoma. Group 3 consisted of 5 patients with presumed CNS lymphoma. Patients underwent FDG-PET studies as an adjunctive diagnostic procedure. The metabolic activity of each patient's lesion was graded using both a qualitative visual score and a semi-quantitative count ratio comparing the lesion with contralateral brain. CNS lesions diagnosed as lymphomas had statistically higher visual scores ( P =0.001) and count ratios ( P =0.002) than CNS lesions diagnosed as infections. FDG-PET could accurately differentiate lymphoma from infections in 16 of 18 cases. Two cases of PML had high metabolic activity and could not be differentiated from lymphoma. FDG-PET shows great promise in differentiating lymphoma from infectious lesions in the CNS of patients with HIV infection. If larger prospective studies confirm this impression, more specific and rapid treatment of CNS lesions could be performed and perhaps obviate the need for brain biopsy in many cases.

Positron Emission Tomography of Cocaine Binding Sites on the Dopamine Transporter

1994 ◽  
Author(s):  
Bertha K. Madras ◽  
◽  
David R. Elmaleh ◽  
Peter C. Meltzer ◽  
Anna Y. Liung ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Dopamine Transporter ◽  
Binding Sites ◽  
Emission Tomography ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document